Noncovalent Inhibitors of SARS-CoV-2 Main Protease: 
A Rescaffolding Attempt

Tim Krischuns; Sylvain Paisant; Kuang-Yu Chen; Laura N. Thirion; Agnès Zettor; Jeanne Chiaravalli; Yves Jacob; Marco Bellinzoni; Nadia Naffakh; Yves L. Janin

doi:10.1055/a-2519-9876

Synthesis, Inhaltsverzeichnis

Synthesis 2025; 57(09): 1627-1634
DOI: 10.1055/a-2519-9876

paper

Noncovalent Inhibitors of SARS-CoV-2 Main Protease: A Rescaffolding Attempt

Tim Krischuns

^aRNA Biology and Influenza Virus Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, 25-28 rue du Dr. Roux, 75015 Paris, France

,

Sylvain Paisant

^aRNA Biology and Influenza Virus Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, 25-28 rue du Dr. Roux, 75015 Paris, France

,

Kuang-Yu Chen

^aRNA Biology and Influenza Virus Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, 25-28 rue du Dr. Roux, 75015 Paris, France

,

Laura N. Thirion

^bStructure et Instabilité des Génomes (StrInG), Muséum National d′Histoire Naturelle, INSERM, CNRS, Alliance Sorbonne Université, 75005 Paris, France

,

Agnès Zettor

^cChemogenomic and Biological Screening Core Facility, Institut Pasteur, Université Paris Cité, CNRS UMR 3523, Paris, France

,

Jeanne Chiaravalli

^cChemogenomic and Biological Screening Core Facility, Institut Pasteur, Université Paris Cité, CNRS UMR 3523, Paris, France

,

Yves Jacob

^dMolecular Genetics of RNA Viruses Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, 25-28 rue du Dr. Roux, 75015 Paris, France

,

Marco Bellinzoni

^eStructural Microbiology Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3528, 25-28 rue du Dr. Roux, 75015 Paris, France

,

Nadia Naffakh

^aRNA Biology and Influenza Virus Unit, Institut Pasteur, Université Paris Cité, CNRS UMR 3569, 25-28 rue du Dr. Roux, 75015 Paris, France

,

Yves L. Janin

^bStructure et Instabilité des Génomes (StrInG), Muséum National d′Histoire Naturelle, INSERM, CNRS, Alliance Sorbonne Université, 75005 Paris, France

› Institutsangaben

Abstract

Alle Artikel dieser Rubrik

Abstract

Out of the results of the sole large-scale screening for inhibitors of SARS-CoV-1 main protease reported in 2013, attempts to improve the identified 3-pyridyl-bearing hits have been conducted in research laboratories, either on this enzyme or more recently on the closely related SARS-CoV-2 main protease. From the resulting structural information reported, we sought to design analogues featuring some of the components providing an affinity for the active site of these proteases along with a different scaffold, which would allow for further structure-activity relationship studies and/or pharmacological improvements. We describe here the introduction of a bridging component with the aim of stabilizing the ligand conformation adopted when bound to these proteases. Accordingly, this led us to prepare 3,3-disubstituted piperazin-2-ones from an array of ketones, via either a Bargellini reaction or a multistage condensation/cyclization/hydrolysis involving ethylene diamine and potassium cyanide. However, even the most elaborate and lipophilic biphenyl-bearing analogues displayed only a weak effect in a bioluminescence-based SARS-CoV-2 main protease inhibition assay.

Key words

medicinal chemistry - phase-transfer catalysis - SARS-CoV-2 main protease - Bargellini reaction - piperazinone

Volltext

Referenzen

Bibliography
1 Janin YL. RSC Med. Chem. 2024; 15: 81

2a Turlington M, Chun A, Tomar S, Eggler A, Grum-Tokars V, Jacobs J, Daniels JS, Dawson E, Saldanha A, Chase P, Baez-Santos YM, Lindsley CW, Hodder P, Mesecar AD, Stauffer SR. Bioorg. Med. Chem. Lett. 2013; 23: 6172
2b Jacobs J, Grum-Tokars V, Zhou Y, Turlington M, Saldanha SA, Chase P, Eggler A, Dawson ES, Baez-Santos YM, Tomar S, Mielech AM, Baker SC, Lindsley CW, Hodder P, Mesecar A, Stauffer SR. J. Med. Chem. 2013; 56: 534

3 St John SE, Anson BJ, Mesecar AD. Sci. Rep. 2016; 6: 25961
4 Lockbaum GJ, Reyes AC, Lee JM, Tilvawala R, Nalivaika EA, Ali A, Kurt Yilmaz N, Thompson PR, Schiffer CA. Viruses 2021; 13: 174
5 Douangamath A, Fearon D, Gehrtz P, Krojer T, Lukacik P, Owen CD, Resnick E, Strain-Damerell C, Aimon A, Ábrányi-Balogh P, Brandão-Neto J, Carbery A, Davison G, Dias A, Downes TD, Dunnett L, Fairhead M, Firth JD, Jones SP, Keeley A, Keserü GM, Klein HF, Martin MP, Noble ME. M, O’Brien P, Powell A, Reddi RN, Skyner R, Snee M, Waring MJ, Wild C, London N, von Delft F, Walsh MA. Nat. Commun. 2020; 11: 5047

6a vo Delft F, Calmiano M, Chodera J, Griffen E, Lee A, London N, Matviuk T, Perry B, Robinson M, von Delft A. Nature 2021; 594: 330
6b Zaidman D, Gehrtz P, Filep M, Fearon D, Gabizon R, Douangamath A, Prilusky J, Duberstein S, Cohen G, Owen CD, Resnick E, Strain-Damerell C, Lukacik P, Covid Moonshot Consortium Barr H, Walsh MA, von Delft F, London N. Cell Chem. Biol. 2021; 28: 1795
6c Kitamura N, Sacco MD, Ma C, Hu Y, Townsend JA, Meng X, Zhang F, Zhang X, Ba M, Szeto T, Kukuljac A, Marty MT, Schultz D, Cherry S, Xiang Y, Chen Y, Wang J. J. Med. Chem. 2022; 65: 2848
6d Ma C, Xia Z, Sacco MD, Hu Y, Townsend JA, Meng X, Choza J, Tan H, Jang J, Gongora MV, Zhang X, Zhang F, Xiang Y, Marty MT, Chen Y, Wang J. J. Am. Chem. Soc. 2021; 143: 20697
6e Luttens A, Gullberg H, Abdurakhmanov E, Vo DD, Akaberi D, Talibov VO, Nekhotiaeva N, Vangeel L, De Jonghe S, Jochmans D, Krambrich J, Tas A, Lundgren B, Gravenfors Y, Craig AJ, Atilaw Y, Sandström A, Moodie LW. K, Lundkvist Å, van Hemert MJ, Neyts J, Lennerstrand J, Kihlberg J, Sandberg K, Danielson UH, Carlsson J. J. Am. Chem. Soc. 2022; 144: 2905
6f Fink EA, Bardine C, Gahbauer S, Singh I, Detomasi T, White K, Gu S, Wan X, Chen J, Ary B, Glenn I, O’Connell J, O’Donnell H, Fajtová P, Lyu J, Vigneron S, Young NJ, Kondratov IS, Alisoltani A, Simons LM, Lorenzo-Redondo R, Ozer EA, Hultquist JF, O’Donoghue AJ, Moroz Y, Taunton J, Renslo AR, Irwin JJ, García-Sastre A, Shoichet BK, Craik CS. Protein Sci. 2023; 32: e4712
6g See also ref. 7.

7 Boby ML, Fearon D, Ferla M, Filep M, Koekemoer L, Robinson MC, Covid Moonshot Consortium Chodera JD, Lee AA, London N, von Delft A, von Delft F. Science 2023; 382, eabo7201
8 Han SH, Goins CM, Arya T, Shin WJ, Maw J, Hooper A, Sonawane DP, Porter MR, Bannister BE, Crouch RD, Lindsey AA, Lakatos G, Martinez SR, Alvarado J, Akers WS, Wang NS, Jung JU, Macdonald JD, Stauffer SR. J. Med. Chem. 2022; 65: 2880

9a Lai JT. J. Org. Chem. 1980; 45: 754
9b Snowden TS. ARKIVOC 2012; (ii): 20
9c Ostermeier M, Sieger P. WO 2014012859, 2014: 15
9d Serafini M, Murgia I, Giustiniano M, Pirali T, Tron GC. Molecules 2021; 26: 558

10 Peschke B, Ankersen M, Hansen TK, Hansen BS, Lau J, Nielsen KK, Raun K. Eur. J. Med. Chem. 2000; 35: 599
11 Desai LV, Ren DT, Rosner T. Org. Lett. 2010; 12: 1032
12 Strong JS, Graig WE, Elkind VT. US 2700668, 1955

13a Masuzawa K, Masaki M, Ohta M. Bull. Chem. Soc. Jpn. 1968; 41: 702
13b Sut A, Podesta M, Lattes MA. Chim. Ther. 1969; 4: 167
13c Ito N, Sasaki H, Tai K, Shinohara T. WO 2012036253, 2012

14 Chen KY, Krischuns T, Ortega Varga L, Hariga-Souiai E, Paisant S, Zettor A, Chiaravalli J, Delpal A, Courtney D, O’Brien A, Baker SC, Decroly E, Isel C, Agou F, Jacob Y, Blondel A, Naffakh N. Antiviral Res. 2022; 201: 105272
15 Kim Y, Lovell S, Tiew KC, Mandadapu SR, Alliston KR, Battaile KP, Groutas WC, Chang KO. J. Virol. 2012; 86: 11754
16 Jaeschke G, O’Hara F, Plancher JM, Ricci A, Rueher D, Vieira E. WO 2017021384, 2017: 40
17 Janin YL. Beilstein J. Org. Chem. 2022; 18: 1355
18 Takemiya A, Hartwig JF. J. Am. Chem. Soc. 2006; 128: 14800
19 Peña-López M, Piehl P, Elangovan S, Neumann H, Beller M. Angew. Chem. Int. Ed. 2016; 55: 14967

Zusatzmaterial

Supporting Information